Suppliers

PRA Health Sciences

PRA Health Sciences

PRA is a global drug development partner providing strategies and solutions spanning every stage of asset development. Today, we are consistently ranked among the top CROs and best employers in the world, all while striving to reinvent healthcare research tomorrow.

PRA helps develop lifesaving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting. We’re committed to leveraging our expertise and cutting-edge technology in order to expand the possibilities of traditional clinical drug development – and beyond. 

Latest content from PRA Health Sciences

Promise of progress: FDA commitment to enhancing pediatric medicines

Content provided by PRA Health Sciences

Promise of progress: FDA commitment to enhancing pediatric medicines

The Commissioner of the FDA, Scott Gottlieb, recently informed a US House Committee on Appropriations of the agency’s intention to expand its guidance documents on developing drugs in specific disease areas to increase the number of new medicines in these...

Related resource

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...